Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2002;38(3):231–236. doi: 10.1079/IVP2002292

Targeting and expression of antigenic proteins in transgenic plants for production of edible oral vaccines

Schuyler S Korban 1,✉
PMCID: PMC7088994  PMID: 32214771

Summary

Exploiting plants as biological bioreactors for production and delivery of edible oral subunit vaccines is a promising application of biotechnology. Efforts to enhance expression levels of transgenes coding for antigenic proteins by exploiting promoters, targeting sequences, and enhancer elements have produced rather low quantities of the antigen in plant tissues, but enough to induce immune responses in feeding studies. This review will cover components of various gene constructs used in developing plant-based vaccines against a myriad of viral and bacterial diseases. Specifically, it will focus on sequences that are involved in targeting the antigen to mucosal tissues of the intestinal tract, thus enhancing the immunogenicity of the plant-based vaccine as well as those components that result in higher accumulation of the protein within the plant.

Key words: blopharmaceuticals, molecular farming, recombinant proteins, cholera toxin B, Escherichia coli, heat-labile enterotoxin, respiratory syncytial virus, hepatitis B surface antigen

References

  1. Arakawa T., Chong D. K. X., Langridge W. H. R. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotechnol. 1998;16:292–297. doi: 10.1038/nbt0398-292. [DOI] [PubMed] [Google Scholar]
  2. Arakawa T., Yu J., Langridge W. H. R. Synthesis of a cholera toxin B subunit-rotavirus NSP4 fusion protein in potato. Plant Cell Rep. 2001;20:343–348. doi: 10.1007/s002990000312. [DOI] [Google Scholar]
  3. Brennan F. R., Bellaby T., Helliwell S. M., Jones T. D., Kamstrup S., Dalsgaard K., Flock J.-I., Hamilton W. D. O. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J. Virol. 1999;73:930–938. doi: 10.1128/jvi.73.2.930-938.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brennan F. R., Jones T. D., Gilleland L. B., Bellaby T., Xu F., North P. C., Thompson A., Staczek J., Lin T., Johnson J. E., Hamilton W. D. O., Gilleland H. E. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology. 1999;145:211–220. doi: 10.1099/13500872-145-1-211. [DOI] [PubMed] [Google Scholar]
  5. Buetow, D. E., Korban, S. S. Transgenic plants producing viral and bacterial antigens. AgBiotechNet 2, ABN 045, www.agbiotechnet.com; 2000.
  6. Carrillo C., Wigdorovitz A., Oliveros J. C., Zamorano P. L., Sadir A. M., Gómez N., Salinas J., Escribano J. M., Borca M. V. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 1998;72:1688–1690. doi: 10.1128/jvi.72.2.1688-1690.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Castañón S., Marín M. S., Martín-Aonso J. M., Boga J. A., Casais R., Humara J. M., Ordás R. J., Parra F. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. Virol. 1999;73:4452–4455. doi: 10.1128/jvi.73.5.4452-4455.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dalsgaard K., Uttenthal Å., Jones T. D., Xu F., Merryweather A., Hamilton W. D. O., Langeveld J. P. M., Boshuizen R. S., Kamstrup S., Lomonossoff G. P., Porta C., Vela C., Casal J. I., Meloen R. H., Rodgers P. B. Plant-derived vaccine protects target animals against a viral disease. Nature Biotechnol. 1997;15:248–252. doi: 10.1038/nbt0397-248. [DOI] [PubMed] [Google Scholar]
  9. Daniell H., Streatfield J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 2001;6:219–226. doi: 10.1016/S1360-1385(01)01922-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dertzbaugh M. T., Elson C. O. Comparative effectiveness of the cholera toxin B subunits and alkaline phosphatase as carrier for oral vaccines. Infect. Immunol. 1993;61:48–55. doi: 10.1128/iai.61.1.48-55.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dertzbaugh M. T., Elson C. O. Reduction in oral immunogenicity of cholera toxin B subunits by N-terminal peptide addition. Infect. Immunol. 1993;61:384–390. doi: 10.1128/iai.61.2.384-390.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Giddings G., Allison G., Brooks D., Carter A. Transgenic plants as factories for biopharmaccuticals. Nature Biotechnol. 2000;18:1151–1155. doi: 10.1038/81132. [DOI] [PubMed] [Google Scholar]
  13. Gil F., Brun A., Wigdorovitz A., Catala R., Martinez-Torrecuadrada J. L., Casal I., Salinas J., Borca M. V., Escribano J. M. High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett. 2001;488:13–17. doi: 10.1016/S0014-5793(00)02405-4. [DOI] [PubMed] [Google Scholar]
  14. Gómez N., Carrillo C., Salinas J., Parra F., Borca M. V., Escribano J. M. Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology. 1998;249:352–358. doi: 10.1006/viro.1998.9315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gómez N., Wigdorovitz A., Castañón S., Gil F., Ordás R. J., Borca M. V., Escribano J. M. Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch. Virol. 2000;145:1725–1732. doi: 10.1007/s007050070087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guda C., Lee S.-B., Daniell H. Stable expression of a biodegradable protein-based polymer in tobacco chloroplasts. Plant Cell Rep. 2000;19:257–262. doi: 10.1007/s002990050008. [DOI] [PubMed] [Google Scholar]
  17. Haq T. A., Mason H. S., Clements J. D., Arntzen C. J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 1995;268:714–716. doi: 10.1126/science.7732379. [DOI] [PubMed] [Google Scholar]
  18. Huang Z., Dry I., Webster D., Strugnell R., Wesselingh S. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine. 2001;19:2163–2171. doi: 10.1016/S0264-410X(00)00390-X. [DOI] [PubMed] [Google Scholar]
  19. Kapusta J., Modelska A., Figlerowicz M., Pniewski T., Letellier M., Lisowa O., Yusinpv V., Koprowski H., Plucienniczak A., Legocki A. N. A plant-derived vaccine against hepatitis B virus. FASEB J. 1999;13:1796–1799. doi: 10.1096/fasebj.13.13.1796. [DOI] [PubMed] [Google Scholar]
  20. Kota M., Daniell H., Varma S., Garczynski F., Gould F., Moar W. J. Overexpression of the Bacillus thuringiensis Cry2A protein in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects. Proc. Natl Acad. Sci. USA. 1999;96:1840–1845. doi: 10.1073/pnas.96.5.1840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lauterslager T. G. M., Florackb D. E. A., van der Wal T. J., Molthoffb J. W., Langeveld J. P. M., Bosch D., Boersma W. J. A., Hilgers L. A. Th. Oral immunization of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine. 2001;19:2749–2755. doi: 10.1016/S0264-410X(00)00513-2. [DOI] [PubMed] [Google Scholar]
  22. Ma J.K.-C., Hiatt A., Hein M., Vine N. D., Wang F., Stabila P., van Dolleweerd C., Mostov K., Lehner T. Generation and assembly of secretory antibodies in plants. Science. 1995;268:716–719. doi: 10.1126/science.7732380. [DOI] [PubMed] [Google Scholar]
  23. Mason H. S., Ball J. M., Shi J. J., Jiang X., Extes M. K., Arntzen C. J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA. 1996;93:5335–5340. doi: 10.1073/pnas.93.11.5335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mason H. S., Haq T. A., Clements J. D., Arntzen C. J. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 1998;16:1336–1343. doi: 10.1016/S0264-410X(98)80020-0. [DOI] [PubMed] [Google Scholar]
  25. Mason H. S., Lam D. M. K., Arntzen C. J. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl Acad. Sci. USA. 1992;89:11745–11749. doi: 10.1073/pnas.89.24.11745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McGarvey P. B., Hammond J., Dienelt M. M., Hooper D. C., Fu Z. F., Dietzschold B., Koprowski H., Michaels F. H. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology. 1995;13:1484–1487. doi: 10.1038/nbt1295-1484. [DOI] [PubMed] [Google Scholar]
  27. Modelska A., Dietszchold B., Sleysh N., Fu Z. F., Steplewski K., Hooper D. C., Koprowski H., Yusibov V. Immunization against rabies with plant-derived antigen. Proc. Natl Acad. Sci. USA. 1998;95:2481–2485. doi: 10.1073/pnas.95.5.2481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mor T. S., Sternfeld M., Soreq H., Arntzen C. J., Mason H. S. Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnol. Bioengng. 2001;75:259–266. doi: 10.1002/bit.10012. [DOI] [PubMed] [Google Scholar]
  29. Nemchinov L. G., Liang T. J., Rifaat M. M., Mazyad H. M., Hadidi A., Keith J. M. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch. Virol. 2000;145:2557–2573. doi: 10.1007/s007050070008. [DOI] [PubMed] [Google Scholar]
  30. Richter L. J., Thanaval Y., Arntzen C. J., Mason H. S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnol. 2000;18:1167–1171. doi: 10.1038/81153. [DOI] [PubMed] [Google Scholar]
  31. Sandhu J. S., Krasnyanski S. F., Domier L. L., Korban S. S., Osadjan M. D., Buetow D. E. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. 2000;9:127–135. doi: 10.1023/A:1008979525909. [DOI] [PubMed] [Google Scholar]
  32. Sandhu J. S., Osadjan M. D., Krasnyanski S. F., Domier L. L., Korban S. S., Buctow D. E. Enhanced expression of the human respiratory syncytial virus-F gene in apple leaf protoplasts. Plant Cell Rep. 1999;18:394–397. doi: 10.1007/s002990050592. [DOI] [Google Scholar]
  33. Staub J. M., Garcia B., Graves J., Hajdukiewicz P. T. J., Hunter P., Nehra N., Paradkar V., Schlittler M., Carroll J. A., Spatola L., Ward D., Ye G., Russell D. A. High-yield production of a human therapeutic protein in tobacco chloroplasts. Nature Biotechnol. 2000;18:333–338. doi: 10.1038/73796. [DOI] [PubMed] [Google Scholar]
  34. Stöger E., Vaquero C., Torres E., Sack M., Nicholson L., Drossard J., Williams S., Keen D., Perrin Y., Christon P., Fischer R. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol. Biol. 2000;42:583–590. doi: 10.1023/A:1006301519427. [DOI] [PubMed] [Google Scholar]
  35. Streatfield S. J., Jilka J. M., Hood E. E., Turner D. D., Bailey M. R., Mayor J. M., Woodard S. L., Beifuss K. K., Horn M. E., Delaney D. E., Tizard I. R., Howard J. A. Plant-based vaccines: unique advantages. Vaccine. 2001;19:2742–2748. doi: 10.1016/S0264-410X(00)00512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tackaberry E. S., Dudani A. K., Prior F., Tocchi M., Sardana R., Altosaar I., Ganz P. R. Development of biopharmaccuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine. 1999;17:3020–3029. doi: 10.1016/S0264-410X(99)00150-4. [DOI] [PubMed] [Google Scholar]
  37. Tuboly T., Yu W., Bailey A., Degrandis S., Du S., Erickson L., Nagy E. Immunogenicity of procine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine. 2000;18:2023–2028. doi: 10.1016/S0264-410X(99)00525-3. [DOI] [PubMed] [Google Scholar]
  38. Vaucheret H., Beclin C., Fagard M. Post-transcriptional gene silencing in plants. J. Cell Sci. 2001;114:3082–3091. doi: 10.1242/jcs.114.17.3083. [DOI] [PubMed] [Google Scholar]
  39. Yu J., Arakawa T., Langridge W. H. R. Assembly of cholera toxin-antigen fusion proteins in transgenic potato. Transgenics. 2000;40:1–10. [Google Scholar]
  40. Yu J., Langridge W. H. R. A plant-based multicomponent vaccine proteets mice from enteric diseases. Nature Biotechnol. 2001;19:548–552. doi: 10.1038/89297. [DOI] [PubMed] [Google Scholar]
  41. Yusibov V., Koprowski H. Plants as vectors for biomedical products. J. Med. Food. 1998;1:5–12. doi: 10.1089/jmf.1998.1.5. [DOI] [Google Scholar]
  42. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper C., Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl Acad. Sci. USA. 1997;94:5784–5788. doi: 10.1073/pnas.94.11.5784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zeitlin L., Olmsted S. S., Moench T. R., Co M. S., Martinell B. J., Paradkar V. M., Russell D. R., Queen C., Cone R. A., Whaley K. J. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nature Biotechnol. 1998;16:1361–1364. doi: 10.1038/4344. [DOI] [PubMed] [Google Scholar]

Articles from In Vitro Cellular & Developmental Biology are provided here courtesy of Nature Publishing Group

RESOURCES